ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 065

Prosthetic Temporomandibular Joint Replacement in a Cohort of Adolescent Patients with Juvenile Idiopathic Arthritis

Jordan Jones1 and Michael Lypka 2, 1Children's Mercy Kansas City, Kansas City, 2Children's Mercy Kansas City, Kansas City, Missouri

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: juvenile idiopathic arthritis (JIA), surgery, Temporomandibular joint, treatment

  • Tweet
  • Email
  • Print
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Thursday, April 30, 2020

Title: Poster Session 1

Session Type: ACR Abstract Session

Session Time: 6:00PM-7:00PM

Background/Purpose: Temporomandibular joint (TMJ) arthritis is present in 40-96% of children with Juvenile Idiopathic Arthritis (JIA) (1). TMJ arthritis can be difficult to identify, treat, and can cause significant morbidity for patients. Therapy includes conservative measures such as splints, but may also include arthrocentesis, intraarticular corticosteroid injections, and local and systemic biologic therapy. Despite maximal medical therapy, a subset of patients has persistent pain with limitation in range of motion (ROM), and radiographic findings ranging from severe arthritic changes to frank TMJ ankylosis. Concurrent dentofacial deformities may also be present. Prosthetic TMJ replacement, with or without simultaneous orthognathic surgery, is a potential surgical solution, but has predominantly been limited to adults. The purpose of this study is to review a group of adolescent females with JIA who underwent prosthetic TMJ replacement.

Methods: In a retrospective chart review that took place at one tertiary care children’s hospital, patients with a diagnosis of JIA who also underwent alloplastic TMJ replacement were identified through electronic medical record system (EMR) and reviewed. Chart review included analysis of all documents in the EMR, including demographic data, JIA history and therapy, surgical strategy, complications, ROM of TMJ measured by maximal incisal opening in millimeters (mm) and pain scores (4-point Likert scale: none, mild, moderate, severe) obtained pre- and post-operatively.

Results: Five female patients met inclusion criteria, with ages ranging from 15-17 years when TMJ replacement was performed. There were nine total joints replaced with a post-operative follow-up that ranged from 12-30 months. Four patients had polyarticular, seronegative JIA and one had oligoarticular, ANA positive disease. All patients had received previous arthrocentesis with steroid injections and had received multiple biologics without resolution of TMJ disease. One of the patients exhibited overt bilateral TMJ ankylosis. Three of the five patients demonstrated significant dentofacial deformities, all of whom underwent simultaneous or staged orthognathic surgery. All patients had improvement in pain with most (80%) reporting no pain, and all had similar or improved ROM of their TMJ post-operatively (Table 1). There was one delayed postoperative infection with Cutibacterium Acnes that presented 15 months after surgery, which required removal of the implant and reimplantation with a new implant. There have been no complications since reimplantation.

Conclusion: TMJ arthritis in the adolescent JIA population can be difficult to identify and treat. Current medical therapy can be successful, however, in select cases that are refractory to extensive medical therapy, early results show that prosthetic joint replacement maybe a reasonable surgical alternative. With prosthetic joint replacement pain levels were reduced and range of motion was maintained or improved for all patients.

References: 1. Stoll ML, Kau CH, Waite PD, et al. Temporomandibular joint arthritis in Juvenile idiopathic arthritis, now what?. Pediatric Rheumatology. 2018; 16:32.

Figure 1. Pre_ and Post_operative Prosthetic Temporomandibular Joint Replacement

Figure 2. Pre_ and Post_operative Prosthetic Temporomandibular Joint Placement


Disclosure: J. Jones, None; M. Lypka, None.

To cite this abstract in AMA style:

Jones J, Lypka M. Prosthetic Temporomandibular Joint Replacement in a Cohort of Adolescent Patients with Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/prosthetic-temporomandibular-joint-replacement-in-a-cohort-of-adolescent-patients-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prosthetic-temporomandibular-joint-replacement-in-a-cohort-of-adolescent-patients-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology